There is no commercial support for this activity.

About this speaker:

Gregory W Mattingly, MD is an Associate Clinical Professor of Psychiatry and has been a Psychopharmacology Instructor for more than 20 years at The Washington University School of Medicine in St. Louis, Missouri. He earned his medical degree and completed his residency at Washington University where he received a Fulbright Scholarship.

In addition to his clinical and research practice, he has been a consultant and evaluator for both the NFL and MLB.

Dr. Mattingly currently serves on the board of directors for APSARD and the Scientific Program Committee for the World Federation for ADHD. He also serves on the board of Headway House, a regional support program for individuals with chronic mental health conditions. 

Disclosure Statements:

Sheppard Pratt holds the standard that its continuing medical education programs should be free of commercial bias and conflict of interest. In accord with Sheppard Pratt's Disclosure Policy, as well as standards of the Accreditation Council for Continuing Medical Education (ACCME) and the American Medical Association (AMA), all planners, reviewers, speakers and persons in control of content have been asked to disclose any relationship he /she  has with any entity producing, marketing, selling, re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 24 months. All planners, reviewers and speakers have also been asked to disclose any payments accepted for this lecture from any entity besides Sheppard Pratt, and if there will be discussion of any products, services or off-label uses of product(s) during this presentation.

Gregory W. Mattingly, MD reports that he will be discussing commercial products including Antidepressants. This presentation and all the content materials were reviewed to mitigate any identified conflicts of interest. This presentation was initially planned and recorded prior to January 1, 2023; therefore, the financial disclosure statement from the speaker reflects only the preceding 12 months, as was the standard at the time. This enduring activity was last reviewed for content validity on May 13, 2024.  He also reports the following relationships with commercial interest:

Event Planners/Reviewers Disclosures: The following event planners and/or reviewers are reported as having no financial interest, arrangement or affiliation with any entity producing, marketing, selling, re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 24 months: Todd Peters, MD, Deepak Prabhakar, MD, Elizabeth Ryznar, MD, MSc, Louis Marino, MD, Ehsan Syed, MD, Devi Bhuyan, PsyD, Faith Dickerson, PhD, Carrie Etheridge, LCSW-C, Tom Flis, LCPC, Stacey Garnett, RN, MSN, Stephanie M. Robinson, MSN, RN, PMH-BC, NPD-BC, NE-BC , Heather Billings, RN, Lisa Illum, MLIS, MEd, and Jennifer Tornabene.